BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27423423)

  • 1. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
    O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolomic detection of lung cancer biomarkers in sputum.
    Cameron SJ; Lewis KE; Beckmann M; Allison GG; Ghosal R; Lewis PD; Mur LA
    Lung Cancer; 2016 Apr; 94():88-95. PubMed ID: 26973212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of an artificial neural network model for selection of potential lung cancer biomarkers.
    Ligor T; Pater Ł; Buszewski B
    J Breath Res; 2015 May; 9(2):027106. PubMed ID: 25944812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
    Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
    Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF and IL-18 in induced sputum of lung cancer patients.
    Rovina N; Hillas G; Dima E; Vlastos F; Loukides S; Veldekis D; Roussos C; Alhanatis M; Bakakos P
    Cytokine; 2011 Jun; 54(3):277-81. PubMed ID: 21398142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
    Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
    Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
    [No Abstract]   [Full Text] [Related]  

  • 10. A Highly Efficient Gene Expression Programming (GEP) Model for Auxiliary Diagnosis of Small Cell Lung Cancer.
    Yu Z; Lu H; Si H; Liu S; Li X; Gao C; Cui L; Li C; Yang X; Yao X
    PLoS One; 2015; 10(5):e0125517. PubMed ID: 25996920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution metabolomics to discriminate compounds in serum of male lung cancer patients in South Korea.
    Pamungkas AD; Park C; Lee S; Jee SH; Park YH
    Respir Res; 2016 Aug; 17(1):100. PubMed ID: 27506545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum discrimination of early-stage lung cancer patients using electrospray-ionization mass spectrometry.
    Hocker JR; Peyton MD; Lerner MR; Mitchell SL; Lightfoot SA; Lander TJ; Bates-Albers LM; Vu NT; Hanas RJ; Kupiec TC; Brackett DJ; Hanas JS
    Lung Cancer; 2011 Nov; 74(2):206-11. PubMed ID: 21529985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Metabolomics Study of Nonsmoking Female Patients with Non-Small Cell Lung Cancer Using Gas Chromatography-Mass Spectrometry.
    Mu Y; Zhou Y; Wang Y; Li W; Zhou L; Lu X; Gao P; Gao M; Zhao Y; Wang Q; Wang Y; Xu G
    J Proteome Res; 2019 May; 18(5):2175-2184. PubMed ID: 30892048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panels of tumor-derived RNA markers in peripheral blood of patients with non-small cell lung cancer: their dependence on age, gender and clinical stages.
    Chian CF; Hwang YT; Terng HJ; Lee SC; Chao TY; Chang H; Ho CL; Wu YY; Perng WC
    Oncotarget; 2016 Aug; 7(31):50582-50595. PubMed ID: 27418131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
    Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
    J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Huang J; Mondul AM; Weinstein SJ; Koutros S; Derkach A; Karoly E; Sampson JN; Moore SC; Berndt SI; Albanes D
    Br J Cancer; 2016 Oct; 115(9):1087-1095. PubMed ID: 27673363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.
    Ostroff RM; Bigbee WL; Franklin W; Gold L; Mehan M; Miller YE; Pass HI; Rom WN; Siegfried JM; Stewart A; Walker JJ; Weissfeld JL; Williams S; Zichi D; Brody EN
    PLoS One; 2010 Dec; 5(12):e15003. PubMed ID: 21170350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomic profiling of dried blood spots reveals gender-specific discriminant models for the diagnosis of small cell lung cancer.
    Yu L; Li K; Li X; Guan C; Sun T; Zhang X
    Aging (Albany NY); 2020 Jan; 12(1):978-995. PubMed ID: 31929115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.